PetaGene Collaborates with NetApp to Offer Simpler Genomic Data Services and Quicker Data Analysis

PetaGene Collaborates with NetApp to Offer Simpler Genomic Data Services and Quicker Data Analysis

PetaGene, the Cambridge, UK-based leaders in genomic data compression today announced that they have become a NetApp Alliance Partner. Combining PetaGene’s expertise in compression techniques specifically designed for genomic data with NetApp’s...

Read more
Medicinal Genomics announces Cannabis Pan-Genome project, a major advance in genetics for cannabis breeding

Medicinal Genomics announces Cannabis Pan-Genome project, a major advance in genetics for cannabis breeding

Medicinal Genomics Corp. (MGC), a pioneer in using genomics to improve the quality, quantity and safety of cannabis, announced the initiation of a cannabis pan-genome project, a comparative genetic analysis of several different cannabis cultivars...

Read more
HitGen Announces Achievement of Milestone from DEL Discovery Alliance with Merck & Co., Inc., Kenilworth, NJ., USA

HitGen Announces Achievement of Milestone from DEL Discovery Alliance with Merck & Co., Inc., Kenilworth, NJ., USA

Hitgen Inc., announced today that it has achieved a milestone in its discovery alliance with Merck & Co. Inc., Kenilworth NJ, USA, known as MSD outside the United States and Canada. The milestone was for the identification of candidates...

Read more
Realbio Completes $15 Million Series A+ for Genome and Microbiome Screening

Realbio Completes $15 Million Series A+ for Genome and Microbiome Screening

Realbio Technology (RBT), a Shanghai genomic screening company, raised $15 million in a Series A+ funding. The company has a dual focus on colorectal and microbiome screening. RBT operates in three areas: REALGENE provides scientific research...

Read more
Crop to Enter Oklahoma Medical Cannabis Market

Crop to Enter Oklahoma Medical Cannabis Market

Crop Infrastructure Corp. (CSE: CROP) (OTC: CRXPF) (Frankfurt: 2FR) announced today that it has identified multiple Tenants for a roll out strategy to enter Oklahoma to target the Medical Cannabis market focusing on Cultivation, Extraction and...

Read more
I-Mab Forms CDMO Partnership with WuXi Biologics

I-Mab Forms CDMO Partnership with WuXi Biologics

I-Mab Biopharma of Shanghai formed a process development partnership with WuXi Biologics to use WuXi Bio’s expertise for CMC development of at least five programs and commercial manufacturing of at least one program for its proprietary...

Read more
JF Healthcare Raises $5 Million for AI-Medical Image Diagnoses in Rural China

JF Healthcare Raises $5 Million for AI-Medical Image Diagnoses in Rural China

JF Intelligent Healthcare Technology of Nanchang raised $5 million from GreyBird Ventures, a US firm, to support its efforts to develop intelligent technologies for better diagnoses at China community healthcare providers in tier three and four...

Read more
CASI Pharma Pays $7.7 Million for Global Rights to CD38 Immunotherapy

CASI Pharma Pays $7.7 Million for Global Rights to CD38 Immunotherapy

CASI, a US in-licensing pharma with operations in China, acquired global rights to an investigational anti-CD38 immunotherapy from Black Belt Therapeutics of the UK. CASI made a $5.5 million upfront payment and invested $2.2 million in Black...

Read more
China News Weekly 106 – China’s General Lithium to launch 60,000 T spodumene converter by end of 2020

China News Weekly 106 – China’s General Lithium to launch 60,000 T spodumene converter by end of 2020

  Click here to find more details This is NAI’s new China News Weekly. We will be covering the latest Chinese foreign investment trends every week. To continue to receive our China News Weekly, please click Here to subscribe.

Read more
Canopy Growth Expands European Footprint, Acquires Spanish Licensed Cannabis Producer Cafina

Canopy Growth Expands European Footprint, Acquires Spanish Licensed Cannabis Producer Cafina

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) is pleased to announce that it has completed an all-cash acquisition of Spain-based licensed cannabis producer Cáñamo y Fibras Naturales...

Read more
Servier Partners with Mitsubishi to Promote Diabetes Treatment in China

Servier Partners with Mitsubishi to Promote Diabetes Treatment in China

Servier Pharma (Tianjin) signed a strategic cooperation agreement with Mitsubishi Tanabe Pharma to promote Mitsubishi’s type 2 diabetes treatment drug Tenelia® (teneligliptin), a DPP-4 inhibitor, in mainland China. MTPC has completed the...

Read more
BioAtla Subsidiary, Himalaya Therapeutics, Will Develop And Commercialize CAB Products In Greater China Market

BioAtla Subsidiary, Himalaya Therapeutics, Will Develop And Commercialize CAB Products In Greater China Market

First Conditionally Active Biologics licensing participation in Greater China territory BioAtla ®, LLC, a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) protein therapeutics for the...

Read more
Do NOT follow this link or you will be banned from the site!